Our science

OWise is the trusted source for all the information that you will need from cancer diagnosis to treatment and beyond. Created by medical professionals, OWise has been selected by the NHS Innovation Accelerator and is listed in the NHS apps library. It was the first oncology app to be used as a case study by the National Institute of Health and Care Excellence (NICE). OWise has also undergone substantial scientific validation resulting in collaborations with renowned academic researchers and publications in peer-reviewed medical journals.

Read below about the thorough scientific and clinical validation we apply to OWise to assure it is effective and safe. 

 

Accreditations in health care

NICE logo
News
February 25, 2019

NICE exemplar

A case study example in the NICE evidence standard framework for digital health technologies.

Read more
NHS Digital Logo
News
January 1, 2018

NHS approved

OWise is one in five cancer apps listed in the NHS app library.

Read more
EU Flag
News
July 1, 2017

CE-marked: Class I Medical Device

OWise was CE-marked to comply with the European regulatory standards for safety and usage on the 7th of May, 2014.

Read more

More

Clinical studies

The OWise app with the highest ranking score as a patient support app in a German systematic review
Science
September 21, 2023

Evaluating mobile applications for Breast Cancer in Germany: A systematic review

A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.

Read more
The Royal Marsden Logo
Science
June 4, 2020

Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT)

Lidington et al., 2020; BMC. OWise is being assessed by the randomised clinical trial ADAPT at the Royal Marsden NHS Foundation Trust. Find out more here:

Read more
Over the shoulder image of a woman holding a phone with the OWise app home page
Science
June 7, 2016

Patients’ and Health Care Providers’ Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation

Young-Afat et al., 2016; JMIR Cancer. Independent study analysed OWise app. Read more to know what the study found!

Read more

More

Scientific publications

The OWise app with the highest ranking score as a patient support app in a German systematic review
Science
September 21, 2023

Evaluating mobile applications for Breast Cancer in Germany: A systematic review

A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.

Read more
Woman on a bed browsing a phone
Science
September 15, 2019

Evidence of the use of Mobile Apps During Treatment of Breast Cancer: systematic review

Cruz et al., 2019; JMIR. Systematic review concluded that mobile apps for women with breast cancer might be an acceptable information source that can improve patient well-being.

Read more
Hand holding an iPhone in front of a laptop
Science
September 10, 2019

Publicly available apps for cancer survivors: a scoping review

Adam et al., 2019; BMJ Open. Review of 151 cancer apps for individuals living with and beyond cancer.

Read more

More

Medical conferences and awards

Anne and Bruce infant of NESTA banner after winning prize
News
March 10, 2020

OWise wins top NESTA Healthier Lives Data Fund Prize

Px Healthcare won £60,000 in funding from the Scottish Government to keep developing their products and scale them across Scotland.

Read more
David and Anne holding a Cancer Innovation Challenge banner with #datasaveslives on the banner after winning prize money
News
February 4, 2018

OWise receives top prize in Scotland’s Cancer Innovation Challenge

OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!

Read more
bopa logo
Science
December 10, 2017

Is there value in using patient recorded outcome measures to improve toxicity management patients receiving chemotherapy for breast cancer?

2017 Annual British Oncology Pharmacy Association Symposium

Read more

More

Supportive research

News
December 8, 2023

Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App

Px HealthCare (Px), the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence (RWE) study at the San Antonio Breast Cancer Symposium (SABCS).

Read more
Doctor with stethoscope preparing for surgery with gloves
Science
July 11, 2017

Overall Survival Results of Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

Basch et al., 2017; JAMA. A trial investigating the effect of PROs on symptom monitoring during routine cancer treatment.

Read more
Stethoscope kit on a cotton bed
Science
February 20, 2016

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Basch et al., 2016; Journal of Clinical Oncology. A RCT that investigated symptom monitoring with PROs during cancer treatment.

Read more

More